Certara reported a second-quarter 2026 net loss of $6.1 million, reversing net income of $1.5 million a year earlier, even as its software segment grew. Software revenue rose 4% to $48.8 million and software bookings climbed 9% to $50.7 million, while services revenue fell 3% to $44.5 million and services bookings dropped 6% to $47.6 million. Total revenue reached $93.3 million, up 1% from $92.4 million, and management reaffirmed full-year revenue guidance of $367 million to $382 million, or growth of 0% to 4%. The quarter included a workforce reduction touching about 5% of the global workforce, expected to generate roughly $13 million in annualized savings, following the May 8 sale of the Regulatory and Medical Writing business and the creation of two business units in May. Certara spent $17.4 million to complete its $100 million share repurchase program in the quarter, and the board approved an additional $50 million for buybacks in the third quarter; Julien Perrier became Chief Commercial Officer effective August 1, 2026. Diluted loss per share was $0.04, adjusted EBITDA fell 3% to $26.2 million, and operating expenses rose to $58.3 million from $50.4 million.
Certara IncCertara swung to a $6.1M net loss with adjusted EBITDA down 3% and opex up to $58.3M from $50.4M.
